🇺🇸 FDA
Patent

US 8728458

Combination anti-HIV vectors, targeting vectors, and methods of use

granted A61KA61K31/7105A61K38/53

Quick answer

US patent 8728458 (Combination anti-HIV vectors, targeting vectors, and methods of use) held by The Regents of the University of California expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
48
CPC classes
A61K, A61K31/7105, A61K38/53, A61K48/0066, A61P